E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. J Clin Oncol. 2017 Feb 10; 35(5):490-497.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Cetuximab
Chemoradiotherapy
Disease-Free Survival
Drug Administration Schedule
Exanthema
Female
Human papillomavirus 16
Humans
Induction Chemotherapy
Male
Middle Aged
Neutropenia
Oropharyngeal Neoplasms
Papillomavirus Infections
Radiotherapy Dosage
Remission Induction

authors with profiles

Nishant Agrawal